Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study.
Cancers
View this publicationCancers
View this publicationThe EMBO journal
View this publicationEMBO molecular medicine
View this publicationRSC medicinal chemistry
View this publicationCellular and molecular life sciences : CMLS
View this publicationCell reports
View this publicationBioinformatics advances
View this publicationJournal of clinical medicine
View this publicationNature metabolism
View this publicationJournal of lipid research
View this publication